Not yet recruiting
Atrial fibrillation
Not yet recruitingPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
Registered drug
Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
Registered drug
- Disease:Atrial fibrillation
- Substances:ApixabanRegn7508
Countries:
Romania
Romania- Participants:18–64 years · 65+ years
- Substances:Apixaban
- Sponsor:Regeneron Pharmaceuticals Inc.





